🏅 FDA Orphan Designation
Vumon for injection
Teniposide
Manufacturer: Bristol-Myers Squibb Pharmaceutical Research Institute
Indicated for:
FDA-Approved Indications (1)
Precursor T-cell acute lymphoblastic leukemiaOrphan Designation
Induction therapy in patients with refractory childhood acute lymphoblastic leukemia when used in combination with other approved anticancer agents.
Indications & Usage
Induction therapy in patients with refractory childhood acute lymphoblastic leukemia when used in combination with other approved anticancer agents.
💙 Support Programs
View all →Vumon for injection
Bristol-Myers Squibb Pharmaceutical Research Institute
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.